ScholarMate
English简体中文繁體中文
Customer service: 400-1616-289
Sign inSign up
Journal article

Deep immunoglobulin repertoire sequencing depicts a comprehensive atlas of spike-specific antibody lineages shared among COVID-19 convalescents

Yan, Qihong; Zhang, Yudi; Hou, Ruitian; Pan, Wenjing; Liang, Huan; Gao, Xijie; Deng, Weiqi; Huang, Xiaohan; Qu, Linbing; Tang, Congli; He, Ping; Liu, Banghui; Wang, Qian; Zhao, Xinwei; Lin, Zihan; Chen, Zhaoming; Li, Pingchao; Han, Jian; Xiong, Xiaoli*; Zhao, Jincun; Li, Song; Niu, Xuefeng; Chen, Ling*广州医学院; 中国科学院研究生院; 中国科学院; 1; 5
Emerging Microbes & Infections2024-12-31DOI: 10.1080/22221751.2023.2290841
7Reads
CiteSave
Share

Abstract

Neutralizing antibodies are a key component in protective humoral immunity against SARS-CoV-2. Currently, available technologies cannot track epitope-specific antibodies in global antibody repertoires. Thus, the comprehensive repertoire of spike-specific neutralizing antibodies elicited by SARS-CoV-2 infection is not fully understood. We therefore combined high-throughput immunoglobulin heavy chain (IgH) repertoire sequencing, and structural and bioinformatics analysis to establish an antibodyomics pipeline, which enables tracking spike-specific antibody lineages that target certain neutralizing epitopes. We mapped the neutralizing epitopes on the spike and determined the epitope-preferential antibody lineages. This analysis also revealed numerous overlaps between immunodominant neutralizing antibody-binding sites and mutation hotspots on spikes as observed so far in SARS-CoV-2 variants. By clustering 2677 spike-specific antibodies with 360 million IgH sequences that we sequenced, a total of 329 shared spike-specific antibody clonotypes were identified from 33 COVID-19 convalescents and 24 SARS-CoV-2-naive individuals. Epitope mapping showed that the shared antibody responses target not only neutralizing epitopes on RBD and NTD but also non-neutralizing epitopes on S2. The immunodominance of neutralizing antibody response is determined by the occurrence of specific precursors in human naive B-cell repertoires. We identified that only 28 out of the 329 shared spike-specific antibody clonotypes persisted for at least 12 months. Among them, long-lived IGHV3-53 antibodies are likely to evolve cross-reactivity to Omicron variants through accumulating somatic hypermutations. Altogether, we created a comprehensive atlas of spike-targeting antibody lineages in COVID-19 convalescents and antibody precursors in human naive B cell repertoires, providing a valuable reference for future vaccine design and evaluation.

Disciplines and keywords

Keywords
SARS-CoV-2spikeantibodyomicsantibody repertoireepitope mappinglineage tracking
Related
Loading…
  • Germline IGHV3-53-encoded RBD-targeting neutralizing antibodies are commonly present in the antibody repertoires of COVID-19 patients
    Yan, Qihong; He, Ping; Huang, Xiaohan; Luo, Kun; Zhang, Yudi; Yi, Haisu; Wang, Qian; Li, Feng; Hou, Ruitian; Fan, Xiaodi; Li, Pingchao; Liu, Xinglong; Liang, Huan; Deng, Yijun; Chen, Zhaoming; Chen, Yunfei; Mo, Xiaoneng; Feng, Liqiang; Xiong, Xiaoli; Li, Song; Han, Jian; Qu, Linbing*; Niu, Xuefeng*; Chen, Ling*Emerging Microbes & Infections, 2021, 10(1): 1097-1111.Cited by 17
  • Shared IGHV1-69-encoded neutralizing antibodies contribute to the emergence of L452R substitution in SARS-CoV-2 variants
    Yan, Qihong; Hou, Ruitian; Huang, Xiaohan; Zhang, Yanjun; He, Ping; Zhang, Yudi; Liu, Banghui; Wang, Qian; Rao, Haiyue; Chen, Xianying; Zhao, Xinwei; Niu, Xuefeng; Zhao, Jincun*; Xiong, Xiaoli*; Chen, Ling*Emerging Microbes & Infections, 2022, 11(1): 2749-2761.Cited by 5
  • Immunodominant antibody germlines in COVID-19
    Andreano Emanuele; Rappuoli RinoJournal of Experimental Medicine, 2021, 218(5).Cited by 22
View all →

Publication info

Publication status
Published
Journal
Emerging Microbes & Infections
Publication date
2024-12-31
Volume / issue
Vol. 13, Issue 1
Pages
2290841
DOI
10.1080/22221751.2023.2290841
Language
ENGLISH
Output indexing
SCIE
Funding acknowledgment
National Natural Science Foundation of China [82201932, 92269201, 61971187, 32170941]; National Natural Science Foundation of China [2022M710891]; China Postdoctoral Science Foundation [SKLRD-Z-202324]; State Key Laboratory of Respiratory Disease [2060206-202201020428]; Guangzhou Science and Technology Bureau - Municipal Schools and Colleges

Authors

  • Y

    Yan, Qihong (First author)

    chinese acad sci · 1 · guangzhou med univ

  • Z

    Zhang, Yudi

    chinese acad sci · univ chinese acad sci

View all 23 authorsShow fewer authors
  • H

    Hou, Ruitian

    guangzhou med univ

  • P

    Pan, Wenjing

    univ south china

  • L

    Liang, Huan

    1 · guangzhou med univ

  • G

    Gao, Xijie

    5 · guangzhou med univ

  • D

    Deng, Weiqi

    chinese acad sci · univ chinese acad sci

  • H

    Huang, Xiaohan

    1 · guangzhou med univ · chinese acad sci

  • Q

    Qu, Linbing

    chinese acad sci

  • T

    Tang, Congli

  • H

    He, Ping

    chinese acad sci

  • L

    Liu, Banghui

    chinese acad sci

  • W

    Wang, Qian

  • Z

    Zhao, Xinwei

    chinese acad sci

  • L

    Lin, Zihan

    chinese acad sci · univ chinese acad sci

  • C

    Chen, Zhaoming

    chinese acad sci

  • L

    Li, Pingchao

    chinese acad sci

  • H

    Han, Jian

  • X

    Xiong, Xiaoli (Corresponding)

    chinese acad sci

  • Z

    Zhao, Jincun

    1 · guangzhou med univ

  • L

    Li, Song

    univ south china

  • N

    Niu, Xuefeng

    1 · guangzhou med univ

  • C

    Chen, Ling (Corresponding)

    chinese acad sci · guangzhou med univ

Sign in for more features

  • Save this paper in My collections
  • Claim your outputs and generate promotion materials
  • Follow authors for new outputs
  • Join groups and collaborate
Sign up / Sign in

Products

  • ScholarMate
  • InnoCity
  • IRISaaS

Support

  • Help Center
  • Privacy Policy
  • Terms of Service

Contact

Online support: []
Customer service: 400-1616-289
Email: support@scholarmate.com

Follow or download ScholarMate

WeChat QR code
WeChat official account
App download QR code
Download the app
OutputsResearchersResearch institutionsResearch newsIRISaaS

©2026 深圳市科研之友网络服务有限公司

Public security registration badge粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417